The DOI matches its Crossref record; 32 of the 37 references it cites were found in a registry or an index.
Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections
Open accessPublished version of a preprint
Abstract
Vaccination has proven effective against infection with SARS-CoV-2, as well as death and hospitalisation following COVID-19 illness. However, little is known about the effect of vaccination on other acute and post-acute outcomes of COVID-19. Data were obtained from the TriNetX electronic health records network (over 81 million patients mostly in the USA). Using a retrospective cohort study and time-to-event analysis, we compared the incidences of COVID-19 outcomes between individuals who received a COVID-19 vaccine (approved for use in the USA) at least 2 weeks before SARS-CoV-2 infection and propensity score-matched individuals unvaccinated for COVID-19 but who had received an influenza vaccine. Outcomes were ICD-10 codes representing documented COVID-19 sequelae in the 6 months after a confirmed SARS-CoV-2 infection (recorded between January 1 and August 31, 2021, i.e. before the emergence of the Omicron variant). Associations with the number of vaccine doses (1 vs. 2) and age (<60 vs. ≥ 60 years-old) were assessed. Among 10,024 vaccinated individuals with SARS-CoV-2 infection, 9479 were matched to unvaccinated controls. Receiving at least one COVID-19 vaccine dose was associated with a significantly lower risk of respiratory failure, ICU admission, intubation/ventilation, hypoxaemia, oxygen requirement, hypercoagulopathy/venous thromboembolism, seizures, psychotic disorder, and hair loss (each as composite endpoints with death to account for competing risks; HR 0.70-0.83, Bonferroni-corrected p < 0.05), but not other outcomes, including long-COVID features, renal disease, mood, anxiety, and sleep disorders. Receiving 2 vaccine doses was associated with lower risks for most outcomes. Associations between prior vaccination and outcomes of SARS-CoV-2 infection were marked in those <60 years-old, whereas no robust associations were observed in those ≥60 years-old. In summary, COVID-19 vaccination is associated with lower risk of several, but not all, COVID-19 sequelae in those with breakthrough SARS-CoV-2 infection. The findings may inform service planning, contribute to forecasting public health impacts of vaccination programmes, and highlight the need to identify additional interventions for COVID-19 sequelae.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 1×
“23 However, our results highlight that some post-acute outcomes of SARS-CoV-2 (and notably long-COVID presentations) are likely to persist even after successful vaccination of the population, so long as breakthrough infections occur.”
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189 · cited 2×
“The study used TriNetX Analytics, a federated network of linked EHRs recording anonymized data from 59 healthcare organizations (HCOs), primarily in the USA, totalling 81 million patients.”
Self-citationHaas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00947-8 · Cited by 1,564 · cited 1×
“Discussion 304 It is established that vaccination protects against hospitalisation, ICU admission, and death 305 from COVID-19 (Agrawal et al., 2021; Antonelli et al., 2021; Bahl et al., 2021; Butt et al., 306 2021; Cabezas et al., 2021; Glatman-Freedman et al., 2021; Haas et al., 2021; Hyams et al., 307 2021; Mateo-U…”
Royston, P. J., & Parmar, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,537
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 1×
“We investigated the 6-month incidence of all acute and post-acute outcomes which have been shown to be significantly associated with COVID-19 in four large-scale studies based on electronic health records (Al-Aly et al., 2021; Daugherty et al., 2021; Taquet et al., 2021b, 2021a), namely:”
Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Self-citationTaquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 948
Self-citationAntonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., Graham, M. S., Klaser, K., Modat, M., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00460-6 · Cited by 843
Flagged first, then by citations
5 of the 37 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- McEwen, 2021, Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State, Clin. Infect. Dis.
Cited by
Sorted by citations
Items 101–200 of 245
Case–Control Study of Long COVID, Sapporo, Japan
Asakura, T., Kimura, T., Kurotori, I., Kenichi, K., Hori, M., Hosogawa, M., Saijo, M., Nakanishi, K., Iso, H., & Tamakoshi, A. (2023) · Emerging infectious diseases · doi:10.3201/eid2905.221349 · Cited by 11
Aldhawyan, A. F., BuSaad, M. A., Alamri, B. A., Alsaihati, M. I., Alanazi, B. S., alanazi, R. A., & Bahamdan, A. S. (2024) · Journal of Primary Care & Community Health · doi:10.1177/21501319241295686 · Cited by 10
Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC
Menezes, F., Palmeira, J. D. F., Oliveira, J. D. S., Argañaraz, G. A., Soares, C. R. J., Nóbrega, O. D. T., Ribeiro, B. M., & Argañaraz, E. R. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1481963 · Cited by 10
Post-Coronavirus Disease 2019 Syndrome in Japan: An Observational Study Using a Medical Database
Kinugasa, Y., Llamas-Covarrubias, M. A., Ozaki, K., Fujimura, Y., Ohashi, T., Fukuda, K., Higashiue, S., Nakamura, Y., & Imai, Y. (2023) · JMA Journal · doi:10.31662/jmaj.2023-0048 · Cited by 12
Budhiraja, S., Indrayan, A., & Mahajan, M. (2022) · medRxiv · doi:10.1101/2022.07.18.22277740 · Cited by 10
Long COVID and Occupational Medicine Practice
Howard, J., Cloeren, M., & Vanichkachorn, G. (2023) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002961 · Cited by 9
Rudolph, A. E., Akoury, N. A., Bogdanenko, N., Markus, K. J., Whittle, I., Wright, O., Haridy, H., Spinardi, J., McLaughlin, J. M., & Kyaw, M. H. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2474772 · Cited by 9
de Melo, B. P., da Silva, J. A. M., Rodrigues, M. A., Palmeira, J. D. F., Saldanha‐Araújo, F., Argañaraz, G. A., & Argañaraz, E. R. (2025) · Viruses · doi:10.3390/v17050617 · Cited by 10
New symptoms and prevalence of postacute COVID-19 syndrome among nonhospitalized COVID-19 survivors
Albtoosh, A. S., Toubasi, A. A., Oweidat, K. A., Hasuneh, M. M., Alshurafa, A. H., Alfaqheri, D. L., & Farah, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-21289-y · Cited by 9
Tian, W., Ren, X., Han, M., Zhang, Y., Gao, X., Chen, Z., & Zhang, W. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221141802 · Cited by 9
Pastorello, A., Meyer, L., Coste, J., Davisse‐Paturet, C., de Lamballerie, X. N., Melchior, M., Novelli, S., Rahib, D., Bajos, N., Vuillermoz, C., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae174 · Cited by 8
Impact of COVID-19 on Neuropsychiatric Disorders
Zia, N., Ravanfar, P., Allahdadian, S., & Ghasemi, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175213 · Cited by 8
Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions
de Sousa, G. F., Carpes, R. D. M., Silva, C. A. O., Pereira, M. E. P., SILVA, A. C. V. F. D., Coelho, V. A. G. S., Costa, E. P., Mury, F. B., Gestinari, R. D. S., Souza‐Menezes, J., et al. (2023) · Viruses · doi:10.3390/v15071545 · Cited by 10
Shenoy, P. U., Udupa, H., Jyothika, K. S., Babu, S., Nikshita, K., Jain, N., Das, R., & Upadhyai, P. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1303183 · Cited by 8
Cianciulli, A., Santoro, E., Manente, R., Pacifico, A., Comunale, G., Finizio, M., Capunzo, M., Caro, F. D., Franci, G., Moccia, G., et al. (2025) · Infectious Disease Reports · doi:10.3390/idr17030069 · Cited by 7
Carazo, S., Phimmasone, J., Skowronski, D. M., Giguère, K., Ouakki, M., Talbot, D. C., Guay, C.-A., Sauvageau, C., Brousseau, N., & Serres, G. D. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf549 · Cited by 7
Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications
Orendáčová, M., & Kvašňák, E. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.903568 · Cited by 7
Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases?
Razzaque, M. S. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2311837 · Cited by 7
Pacnejer, A.-M., Butucă, A., Dobrea, C. M., Arseniu, A. M., Frum, A., Gligor, F. G., Arseniu, R., Vonica, R. C., Vonica-Țincu, A. L., Oancea, C. I., et al. (2024) · Viruses · doi:10.3390/v16121811 · Cited by 8
Aydın, N., Cihan, Ç., Çelik, Ö., Aslan, A. F., Odabaş, A., Alataş, F., & Yıldırım, H. (2023) · Tuberkuloz ve Toraks · doi:10.5578/tt.20239916 · Cited by 8
Prevalence and characteristics of long COVID-19 in Jordan: A cross sectional survey
Obeidat, M., Zahra, A., & Alsattari, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295969 · Cited by 7
Impact of COVID-19 vaccination on long COVID: a systematic review and meta-analysisPreprint
Byambasuren, O., Stehlik, P., Clark, J. M., Alcorn, K., & Glasziou, P. (2022) · medRxiv · doi:10.1101/2022.06.20.22276621 · Cited by 7
Caspersen, I. H., Skodvin, S. N., Blix, K., Robertson, A. H., Laake, I., Feiring, B., Magnus, P. M., Mjaaland, S., & Trogstad, L. (2025) · Vaccine · doi:10.1016/j.vaccine.2024.126664 · Cited by 6
Richard, S. A., Scher, I., Rusiecki, J. A., Byrne, C., Berjohn, C. M., Fries, A. C., Lalani, T., Smith, A. G., Mody, R. M., Ganesan, A., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad579 · Cited by 6
Lee, E. K., & Auger, R. R. (2024) · Current Sleep Medicine Reports · doi:10.1007/s40675-024-00299-4 · Cited by 6
Swift, M. D., Breeher, L. E., Dierkhising, R., Hickman, J. A., Johnson, M. G., Roellinger, D. L., & Virk, A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae495 · Cited by 6
Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: The VENUS study
Kim, S. A., Maeda, M., Murata, F., & Fukuda, H. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126497 · Cited by 6
Renner, K., Stauffenberg, F., Paulus, M., Neumayer, S., Winter, F., Buchtler, S., Schmalenberger, D., Blaas, S. H., Mohr, A., Pfeifer, M. A., et al. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110502 · Cited by 7
Long COVID: A Systematic Review of Preventive Strategies
Park, S. O., & Nanda, N. (2025) · Infectious Disease Reports · doi:10.3390/idr17030056 · Cited by 6
Yavuz, S. Ş., Tunçer, G., Aydın, Ö. A., Aydın, M., Pehlıvanoglu, F., Tok, Y., Meşe, S., Gündüz, A., Geyiktepe-Güçlü, C., Özdoğan, İ., et al. (2022) · Vaccines · doi:10.3390/vaccines10050733 · Cited by 7
SARS-CoV-2 infection outcomes associated with the Delta variant: A prospective cohort study
Gallant, M., Rioux‐Perreault, C., Lemaire‐Paquette, S., & Piché, A. (2022) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2022-0022 · Cited by 5
Maria, L. D., Delvecchio, G., Sponselli, S., Cafaro, F., Caputi, A., Giannelli, G., Stefanizzi, P., Bianchi, F. P., Stufano, A., Tafuri, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216800 · Cited by 7
S1 Leitlinie Long/Post-COVID-Syndrom
Gogoll, C., Peters, E. M. J., Köllner, V., & Koczulla, A. R. (2024) · Die Urologie · doi:10.1007/s00120-024-02373-9 · Cited by 6
Stellenwert der COVID-19-Impfung im Kontext von Long-COVID
Bauernfeind, S., & Schmidt, B. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01368-y · Cited by 6
The use of prescription drugs and health care services during the 6-month post-COVID-19 period
Mooses, K., Vesilind, K., Oja, M., Tamm, S., Haug, M., Kalda, R., Suija, K., Tisler, A., Meister, T., Malk, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38691-9 · Cited by 5
Fang, L.-C., Ming, X.-P., Cai, W.-Y., Hu, Y., Hao, B., Wu, J., Tuohuti, A., & Chen, X. (2024) · Virology Journal · doi:10.1186/s12985-024-02400-3 · Cited by 5
Post-Acute COVID-19 Syndrome and Stroke
Araújo-Filho, I., & do Rêgo, A. C. M. (2024) · JOURNAL OF SURGICAL AND CLINICAL RESEARCH · doi:10.20398/jscr.v15i1.35636 · Cited by 5
Al‐Khrasani, M., Essmat, N., Boldizsár, I., Varga, B. T., Chalabiani, Y., Abbood, S. K., Ernyey, A. J., Király, K. P., Máté, A., Riba, P., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118346 · Cited by 8
Goërtz, Y. M. J., Spruit, M. A., Herck, M. V., Dukers–Muijrers, N. H. T. M., Boezen, H. M., Mierau, J. O., Franke, H. L., Dekens, J. A. M., Deelen, P., Lanting, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38223-5 · Cited by 5
High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patients
Abdellati, K. E., Lucas, A., Perron, H., Tamouza, R., Nkam, I., Richard, J., Fried, S., Barau, C., Djonouma, N., Pinot, A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.014 · Cited by 5
Real-world data analysis of post-COVID-19 condition risk in older patients
Liu, T., Huang, P., Wu, J., Chuang, M., Hsu, W., Tsai, Y., Tsai, M.-H., & Lai, C. (2023) · Age and Ageing · doi:10.1093/ageing/afad204 · Cited by 5
Luo, H., Luo, D., Tang, Q., Niu, Z., Xu, J., & Li, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1298693 · Cited by 5
Hsu, Y., Chen, P., Tsai, Y., Wei, C.-H., Wu, L. S.-H., Hsieh, K., Hsieh, M.-H., Lai, H., Lin, C., Lin, H., et al. (2024) · Vaccines · doi:10.3390/vaccines12080910 · Cited by 5
Cassiano, L. M. G., de Paula, J. J., Rosa, D. V., de Miranda, D. M., Romano‐Silva, M. A., & Coimbra, R. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-86637-0 · Cited by 7
Chuang, C., Wang, Y., Yeh, L., & Yeh, C. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70351 · Cited by 4
Vaccination and COVID-19: impact on long-COVID
Guimarães, G. N., Brunetti, N. S., de Lima, D. G., Proença-Módena, J. L., & Farias, A. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1686572 · Cited by 6
Unfavorable Outcome and Long-Term Sequelae in Cases with Severe COVID-19
Fabbri, A., Voza, A., Riccardi, A., Vanni, S., & Iaco, F. D. (2023) · Viruses · doi:10.3390/v15020485 · Cited by 5
Woo, M. S., Mayer, C., Brehm, T. T., Andersen, G., Weigel, A., Löwe, B., Lohse, A. W., Addo, M. M., Gerloff, C. P., Knobloch, J. K. ‐., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad092 · Cited by 4
Patil, S. M., Patil, S., & Gondhali, G. (2023) · South Asian Research Journal of Applied Medical Sciences · doi:10.36346/sarjams.2023.v05i04.005 · Cited by 4
Semen proteomics reveals alterations in fertility-related proteins post-recovery from COVID-19
Dash, A., Salkar, A., Nissa, M. U., Makwana, P., Athalye, A. S., Parikh, S., Srivastava, S., & Parikh, F. R. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1212959 · Cited by 4
Murata, F., Maeda, M., Murayama, K., Nakao, T., & Fukuda, H. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.018 · Cited by 4
The fast-track development of COVID-19 vaccines
El‐Maradny, Y. A., Ramadan, A. A., Chavda, V. P., Balar, P. C., & Redwan, E. M. M. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00027-8 · Cited by 5
Li, C., & Chen, H. (2024) · Medicine · doi:10.1097/md.0000000000041015 · Cited by 4
Ng, T. K. S., Beydoun, H. A., Ah, D. M. V., Shadyab, A. H., Wong, S. C., Freiberg, M. S., Ikramuddin, F. S., Nguyen, P. K. P., Gradidge, P. J.-L., Qi, L., et al. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002490 · Cited by 4
Sadowski, J., Ostrowska, S. A., Klaudel, T., Zaborska, M., Chruszcz, M., Sztangreciak-Lehun, A., & Bułdak, R. J. (2025) · Journal of NeuroVirology · doi:10.1007/s13365-025-01242-1 · Cited by 4
Antimicrobial therapies for chronic pain (part 2): the prevention and treatment of chronic pain
Wang, E. J., Dolomisiewicz, E., Karri, J. V., Tontisirin, N., & Cohen, S. P. (2023) · The Korean journal of pain · doi:10.3344/kjp.23130 · Cited by 4
Wu, W., Zheng, X., Ding, H., Miao, T., Zang, Y., Shen, S., & Gao, Y. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2345505 · Cited by 4
Blumberg, Y., Edelstein, M. L., Jabal, K. A., Golan, R., Tuvia, N., Perets, Y., Saad, M. M., Levinas, T., Saleem, D., Israeli, Z., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154420 · Cited by 4
Shielding under endemic SARS-CoV-2 conditions is easier said than done: a model-based analysisPreprint
Stoddard, M., Lin, Y., Sarkar, S., Mazewski, M., Egeren, D. V., Mangalaganesh, S., Nolan, R. P., Rogers, M. S., Hather, G., White, L. F., et al. (2023) · medRxiv · doi:10.1101/2023.01.22.23284884 · Cited by 3
Lewnard, J. A., Malden, D. E., Hong, V. X., Skela, J., Feldstein, L. R., Saydah, S., Reyes, I., Hechter, R. C., Sy, L. S., Ackerson, B. K., et al. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004777 · Cited by 6
SARS‐CoV‐2 Infection, Vaccination Status, and Dementia Risk: A Nested Case–Control Study
Zur, N., Stein, N., Saliba, W., & Weinstein, G. (2026) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70277 · Cited by 3
Sequelas da Covid-19 e o papel da fisioterapia na reabilitação do paciente
Costa, C. S., Almeida, V. A. L., Oliveira, I. G. B., Oliveira, J. D. C. N. D., Bezerra, E. A. G., Lopes, M. C. S., Pereira, W. V. S., Barbosa, P. G. P., Barbosa, R. D. L., & Júnior, M. A. B. (2022) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e10052.2022 · Cited by 3
Brunner‐Ziegler, S., Bäuerle, M., Brühl, P., Kornek, G. V., Parschalk, B., Savic, R., Schnetzinger, M., Spath, T., Straßl, R. P., Handisurya, A., et al. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.02.017 · Cited by 4
A Critical Assessment of COVID-19 Genomic Vaccines
Sabbah, D. A., Hajjo, R., & Sunoqrot, S. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230825094341 · Cited by 4
COVID-19 infection associated with poorer mental health in a representative population sample
Batterham, P. J., Dawel, A., Shou, Y., Gulliver, A., Cherbuin, N., Calear, A. L., Farrer, L. M., & Monaghan, C. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111588 · Cited by 4
Neuropsychiatric sequelae of COVID-19 after vaccination: A gathering storm?
Rogers, J. P., & Rooney, A. G. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.07.166 · Cited by 3
ĐẶC ĐIỂM HẬU COVID-19 TẠI ĐẮK LẮK, NĂM 2021
Khuê, N. N. N., Hậu, V. T. Q., Khoa, N. A., Phúc, L., & Huyên, N. H. (2022) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v513i1.2362 · Cited by 3
Lippke, S., Rinn, R., Derksen, C., & Dahmen, A. (2023) · Vaccines · doi:10.3390/vaccines11030691 · Cited by 3
Rahman, A. U., Ikram, M. T., Arif, A., Khan, B. D., Azam, K. U., Fida, M. S., Rahim, A. K., Khan, M. S., Mushtaq, M. H., Fida, R., et al. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000606 · Cited by 3
Kontowicz, E., Harland, K. K., Stubbs, A. M., Beiser, D. G., Plumb, I. D., Krishnadasan, A., Talan, D. A., & Mohr, N. M. (2025) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2025.103233 · Cited by 2
Bhargava, A., Patel, H., Szpunar, S. M., Sharma, M., Somero, M. S., Moudgil, S. S., & Saravolatz, L. D. (2025) · Viruses · doi:10.3390/v17121551 · Cited by 2
Healthcare response strategies for the long-COVID era
Kim, H. J., Song, J., & Park, S. M. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.1.50 · Cited by 2
SARS-CoV-2 and COVID-19: From Crisis to Solution
Šalamon, Š., Ewing, A. G., Fox, G., Bilodeau, S., Gershenson, C., Heino, M. T. J., & Bar-Yam, Y. (2024) · doi:10.59454/whn-2401-334 · Cited by 3
Sinus Tachycardia Following COVID-19 and Its Implications
Amir-Kabirian, B., Annie, F., Koontz, M. B., & Ihle, R. (2024) · Cureus · doi:10.7759/cureus.57320 · Cited by 2
Sumi, T., & Harada, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1329162 · Cited by 3
Trends of common laboratory biomarkers after SARS-CoV-2 infection
Meirman, T. D., Shapira, B., Balicer, R. D., Rokach, L., & Dagan, N. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106318 · Cited by 2
Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers
Chadda, K. R., Roberts, S. A., Lugg, S. T., Faniyi, A. A., Faustini, S. E., Webster, C., Duffy, J. E., Hewison, M., Shields, A. M., Richter, A. G., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1494129 · Cited by 2
Cognition and Long COVID: A PRISMA Systematic Review of Longitudinal Studies
Pantazi, M. A. T., Gadea, M., & Espert, R. (2025) · Revista de Neurología · doi:10.31083/rn37385 · Cited by 2
Suchy, C., Wiseman, S., Orban, M., & Senn, A. (2022) · Zeitschrift für die gesamte Versicherungswissenschaft · doi:10.1007/s12297-022-00526-3 · Cited by 2
Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study
Saito, Y., Yamamoto, K., Takita, M., Kami, M., Tsubokura, M., & Shibuya, K. (2022) · Vaccines · doi:10.3390/vaccines10111914 · Cited by 2
Functional parameters and affecting factors in post-COVID period
Kızılırmak, D., Fidan, U., Sarı, S., & Havlucu, Y. (2023) · Tuberkuloz ve Toraks · doi:10.5578/tt.20239915 · Cited by 2
Ohno, M., Dzúrová, D., & Šmejkal, P. (2023) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2023-220771 · Cited by 2
Long COVID-19 Syndrome: Insights From a Major Tertiary Center in the UK on Who Is at Greater Risk
Khan, S. T., Rashid, K., Ansar, F., Khan, M. Y., Khan, F. A., Ismaeel, R. E. H. A. A., Mohammed, R. H., Mustafa, R., Khan, B. T., Tariq, B., et al. (2023) · Cureus · doi:10.7759/cureus.50027 · Cited by 2
Health Consequences Among COVID-19 Convalescent Patients 30 Months Post-Infection in China
Yin, Y., Guo, Y., Xiao, M., Chen, Q., Long, P., Wang, X., Wang, J., Shao, Z., Qiu, Y., Lu, Y., et al. (2023) · Zoonoses · doi:10.15212/zoonoses-2023-0014 · Cited by 2
Medical complaints after 3 vs 2 doses SARS-CoV-2 mRNA vaccinationPreprint
Methi, F., Gran, J. M., Valberg, M., Kinge, J. M., Telle, K. E., & Magnusson, K. (2022) · medRxiv · doi:10.1101/2022.07.08.22277413 · Cited by 2
Smits, P. D., Rodriguez, P. J., Gratzl, S., Cartwright, B. M. G., Gilson, S., Lee, R. H., Baker, C., & Stucky, N. L. (2023) · medRxiv · doi:10.1101/2023.04.28.23289271 · Cited by 2
Nady, A., Reichheld, S. E., & Sharpe, S. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.25.591137 · Cited by 2
Long COVID-19 and the potential use of palmitoylethanolamide
Calabrò, R. S., & Raciti, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95650-5.00032-x · Cited by 1
Ren, M. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s499058 · Cited by 1
Zhang, X., Hery, C. M. B., McLaughlin, E. M., Woods, N. F., Neuhouser, M. L., Harris, H. R., Gower, E. W., Wactawski‐Wende, J., Shadyab, A. H., Wallace, R. B., et al. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19434 · Cited by 1
Ayoubkhani, D., Atchison, C. J., Banerjee, A., Brightling, C. E., Calvert, M., Diamond, S. I., Eggo, R. M., Elliott, P., Evans, R. A., Haroon, S. M., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103833 · Cited by 1
Is the vaccine for COVID-19 effective in preventing and treating long COVID?
Kim, S. H., & Kang, H. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i3.3810 · Cited by 1
Rømer, V., Sivapalan, P., Eklöf, J. V., Nielsen, S. D., Harboe, Z. B., Biering‐Sørensen, T., Itenov, T. S., & Jensen, J. S. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2418 · Cited by 1
Comprehensive Risk Assessment of Infection Induced by SARS-CoV-2
Megha, K. B., Reshma, S. C., Amir, S., Krishnan, M. A., Ahlawat, S., Alka, R., & Mohanan, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03682-4 · Cited by 1
Takamatsu, A., Honda, H., Miwa, T., Tabuchi, T., Taniguchi, K., Shibuya, K., & Tokuda, Y. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.02.008 · Cited by 1
UNDERSTANDING THE MOLECULAR BASIS OF JN.1
Raghavendra Rao, M. V., Chennamchetty, V. K., Pavani, G., Dass, M., Basetty, S., Kudari, R., Verma, M. K., Rahman, A., & Rao, P. J. (2024) · International Education and Research Journal · doi:10.21276/ierj24815318066840 · Cited by 1
Long COVID: Sufferers can take heart
Tindle, R. W. (2024) · Australian Journal of General Practice · doi:10.31128/ajgp-07-23-6896 · Cited by 2
Albtoosh, A. S., Farah, R., Oweidat, K. A., Hussein, O. M., Obeid, A. A., Hamila, H. M., Radwan, M. N. M., Ahmad, R. F., Masadeh, H. M., Hammad, A. I., et al. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100495 · Cited by 1
Metadata
- Authors
- Taquet, M., Dercon, Q., & Harrison, P. J.
- Affiliations
- Oxford Health NHS Foundation Trust (GB)
- MRC Cognition and Brain Sciences Unit (GB)
- Corresponding author
- Taquet, Maxime
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 103
- Pages
- 154-162
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC9013695
- OpenAlex
- W4225562523
- Cited by
- 246
- References
- 37
- Citations by year
- 2026: 8 · 2025: 28 · 2024: 68 · 2023: 79 · 2022: 60
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain Behavior and Immunity (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- National Institute for Health and Care Research
- AXA Research Fund (G102329)
- NIHR Oxford Biomedical Research Centre (BRC-1215-20005)
- Medical Research Council (SUAG/077 G101400)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- breakthrough infection, SARS-CoV-2, post-COVID-19 sequelae, long COVID, respiratory failure, intensive care unit admission, intubation and mechanical ventilation, hypoxemia, venous thromboembolism, hypercoagulability, seizures, psychosis, hair loss, vaccine dose number, older adults, Omicron variant
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Post-Acute COVID-19 Syndrome, Humans, Middle Aged, Retrospective Studies, Vaccination, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
